- Home
- WKHS vs SNSE Comparison
WKHS vs SNSE Comparison
Compare WKHS & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | SNSE |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 10.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WKHS | SNSE |
|---|---|---|
| Price | $0.78 | $9.76 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $1.75 | ★ $72.50 |
| AVG Volume (30 Days) | ★ 4.1M | 79.9K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,620,296.00 | N/A |
| Revenue This Year | $92.70 | N/A |
| Revenue Next Year | $34.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.73 | N/A |
| 52 Week Low | $0.53 | $5.00 |
| 52 Week High | $15.75 | $18.35 |
Technical Indicators
Market Signals| Indicator | WKHS | SNSE |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 53.27 |
| Support Level | $0.79 | $7.76 |
| Resistance Level | $0.90 | $9.42 |
| Average True Range (ATR) | 0.14 | 1.35 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 45.67 | 39.07 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).